Dermatitis: all 1,425 studies

Page 13 of 15. Open to participants first (127), then studies with results posted, then the rest; newest registration first within each.

• Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102CompletedNCT01423656Phase 1
• Nickel Desensitization Using Topical TherapyStatus unknownNCT01413477Not applicable
• HPA Axis Study in AdultsCompletedNCT01408511Phase 2
• HPA Axis Study in Japanese AdultsCompletedNCT01407510Phase 2
• Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic DermatitisTerminatedNCT01402414Not applicable
• Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic DermatitisCompletedNCT01385657Phase 1
• Pediatric Atopic Dermatitis (AD) Internet SurveyWithdrawnNCT01385527Not applicable
• A Study Assessing GW870086's Potential to Cause Skin ThinningCompletedNCT01381445Phase 1
• CT 327 in the "Atopy Patch Test" ModelWithdrawnNCT01368315Phase 1
• Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)CompletedNCT01359787Phase 2
• Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic AgentsCompletedNCT01356758
• Effect of Dietary Phospholipids on Atopic DermatitisCompletedNCT01326520Not applicable
• Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic DermatitisCompletedNCT01320579Phase 2
• Vulvar Contact Dermatitis Resulting From Urine IncontinenceWithdrawnNCT01320046
• Chemokine Expression in Nummular Dermatitis and Atopic DermatitisStatus unknownNCT01311986
• Climatotherapy At The Dead Sea For Atopic DermatitisStatus unknownNCT01307150
• The Effects of Emollient Therapy on the Skin BarrierCompletedNCT01291940Not applicable
• Dilute Bleach Baths in Pediatric Patients With Atopic DermatitisTerminatedNCT01286220Not applicable
• Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic DermatitisCompletedNCT01259323Phase 1
• Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)CompletedNCT01244230Phase 2/3
• Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic DermatitisStatus unknownNCT01239719Phase 3
• Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic DermatitisCompletedNCT01238263
• Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic DermatitisTerminatedNCT01234909
• Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in AdultsCompletedNCT01232985Phase 2
• Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic DermatitisCompletedNCT01232543Phase 2
• Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.TerminatedNCT01231854Phase 4
• Management of Eczema by Specific Probiotic StrainsWithdrawnNCT01230190Phase 3
• Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®CompletedNCT01228565Phase 3
• Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)CompletedNCT01228513Phase 2
• Effect of Probiotics in the Atopic DermatitisCompletedNCT01224132Phase 3
• A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin InfectionCompletedNCT01223222Phase 2
• Text Messaging and Atopic DermatitisCompletedNCT01216059Not applicable
• Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic DermatitisCompletedNCT01202149Phase 4
• A Study of E6005 in Japanese Patients With Atopic DermatitisCompletedNCT01179880Phase 1/2
• Atopic Dermatitis Biomarker Identification Trial in Omalizumab UsageCompletedNCT01179529Phase 2
• Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.CompletedNCT01177566Phase 4
• Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic DermatitisStatus unknownNCT01174511Phase 1/2
• Natural History of Severe Allergic Inflammation and ReactionsCompletedNCT01164241
• Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and ImmunityCompletedNCT01148667Phase 4
• Efficacy and Safety of Low-dose Oral Isotretinoin for SeborrheaStatus unknownNCT01139749Phase 4
• Health Literacy for Children With Atopic Dermatitis and Their CaregiversTerminatedNCT01138761Not applicable
• Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the ScalpCompletedNCT01137630Phase 2/3
• Pimecrolimus and Epidermal Barrier FunctionCompletedNCT01132079Not applicable
• Efficacy and Safety of the Association Drugs in Patients With Allergic DermatitisWithdrawnNCT01125761Phase 3
• A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in AdultsCompletedNCT01124318Phase 2/3
• A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic DermatitisTerminatedNCT01122914Phase 1
• Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 CreamCompletedNCT01098734Phase 2
• Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT01079897Not applicable
• Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic DermatitisCompletedNCT01077882Phase 4
• Knowledge Base in the Treatment of Atopic Dermatitis Among Thai PediatriciansCompletedNCT01069666
• Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids ApplicationCompletedNCT01063218Phase 4
• the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk AllergyWithdrawnNCT01045486Not applicable
• Safety and Efficacy of DNK333 in Atopic Dermatitis PatientsCompletedNCT01033097Phase 2
• Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the FaceStatus unknownNCT01024374
• A Randomised Clinical Trial in a Population of Health Care Workers With Hand EczemaStatus unknownNCT01012453Not applicable
• Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive DermatosisStatus unknownNCT01011621Phase 3
• Probiotic Bacteria to Infants With Atopic DermatitisCompletedNCT01007331Not applicable
• A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic DermatitisCompletedNCT01005823Phase 1
• CT 327 in the Treatment of Atopic DermatitisTerminatedNCT00996008Phase 2
• The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of PhotodamageCompletedNCT00991198Phase 2
• Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic DermatitisCompletedNCT00985894Not applicable
• Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic DermatitisCompletedNCT00980629Phase 2
• Sinecort Pilot Efficacy StudyCompletedNCT00980135Phase 2
• Study of Enzyme Supplements to Treat Celiac DiseaseCompletedNCT00962182Phase 1/2
• Assessment of the Phototoxic Potential of LEO 29102 CreamCompletedNCT00958516Phase 1
• Dose Escalation of Different Concentrations of ZK 245186 in Atopic DermatitisCompletedNCT00944632Phase 2
• Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish DermatitisCompletedNCT00944203Phase 2
• A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)CompletedNCT00932074Phase 1/2
• Topical Application of AS101 for the Treatment of Atopic DermatitisTerminatedNCT00927212Phase 2
• Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionCompletedNCT00925730Phase 4
• Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation DermatitisCompletedNCT00894712
• A Study of a Probiotic in Atopic DermatitisCompletedNCT00893230Phase 3
• Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand DermatitisCompletedNCT00890968Phase 2
• A Study of BRT-FC-83C for the Treatment of Atopic DermatitisCompletedNCT00883311Phase 2
• Safety and Efficacy of SRD441 Ointment in Patients With Atopic DermatitisCompletedNCT00882245Phase 2
• Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass IndexCompletedNCT00879944
• Vitamin D Supplementation in Childhood Atopic DermatitisCompletedNCT00879424Not applicable
• Investigation of Efficacy and Safety of EPOGAMCompletedNCT00878670Phase 4
• Trial Comparing Best Supportive Care to Aloe Vera GelCompletedNCT00876642Phase 3
• Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapyWithdrawnNCT00871208Phase 4
• Evaluating for Contact Allergies in Patients With Chronic UrticariaCompletedNCT00868036
• Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact DermatitisCompletedNCT00867607Phase 1/2
• Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind StudyCompletedNCT00863005Phase 1/2
• Retinol-induced Dermatitis in Aged SkinCompletedNCT00857610
• Effect of Moisturising Creams on Skin Moisture in Atopic DermatitisCompletedNCT00846235Phase 4
• Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated PruritusCompletedNCT00838708Phase 2
• Phase IIa Study of WBI-1001 Cream for Atopic DermatitisCompletedNCT00837551Phase 1/2
• Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic DermatitisCompletedNCT00833079Phase 1
• HairMax LaserComb Open Label Study to Treat Seborrheic DermatitisCompletedNCT00830908Not applicable
• Comparison of Video-Based Versus Written Patient Education on Atopic DermatitisCompletedNCT00826592Not applicable
• Exploratory Study of Natural Killer Cells in Human SkinCompletedNCT00824889Not applicable
• Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis PatientsCompletedNCT00822783Phase 4
• The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)CompletedNCT00822276
• Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)CompletedNCT00817076Phase 3
• Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic DiseasesCompletedNCT00815984
• Study of Pimecrolimus Treatment for Atopic Dermatitis of African American ChildrenTerminatedNCT00810862Phase 4
• Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2
• Salmon in Pregnancy StudyCompletedNCT00801502Not applicable
• Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-upCompletedNCT00795496
• Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin IrritationStatus unknownNCT00779792Phase 4

← Dermatitis overview